Searched for
PAEDIATRIC TRIALS
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- World's first epilepsy device fitted in 13 year old UK boy's skull; Here's how the device worksOran Knowlson, a 13-year-old from England with severe epilepsy, has become the first person to trial a new device implanted in his skull to...
- Biological E's Pneumonia jab for kids gets nodStreptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.
- Cannot sit in judgement of leading scientific analysis on safety of paediatric vaccination, says Supreme CourtThe apex court noted that according to the Union of India, the said data would show that the vaccine does not pose threat to the safety of ...
- Covaxin safe and immunogenic in 2-18 age group, says Bharat BiotechThe Hyderabad-based company had conducted phase-2/3, open-label, and multi-centre studies to evaluate the safety, reactogenicity, and immun...
- Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
- Don’t dismantle special health infra as third Covid wave inevitable: Experts’ advice to govt“It is not a question of whether but when. The US, UK, Italy and Japan had four waves. The virus will also replicate like that in India. Bu...
- ‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
- Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
- Bharat Biotech set to begin paediatric trials of Covaxin from June“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addr...
- Oxford University to test COVID-19 vaccine response among children for first timeThe new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed sta...
- SEC denies emergency nod to Natco Covid-19 drugNatco had in December sought a waiver of the clinical trial requirement for the emergency use of baricitinib tablets in Covid-19 treatment,...
- USFDA approves use of remdesivir to treat Covid-19 patients in hospitalsThe approval of Veklury (remdesivir) was supported by the agency’s analysis of data from three randomized, controlled clinical trials that ...
- AstraZeneca to make billion Covid vaccine doses if tests succeedThe British drugmaker said it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing w...
- Ranbaxy gets CDSCO nod to sell malaria drug 'SynriamTM'"This approval makes SynriamTM one of the few therapies in the world that successfully treats both, Plasmodium vivax and Plasmodium falcipa...
- Brokers' Call: ONGC, DRL, Cipla and Coal IndiaWe have compiled stock views and recommendations from various agencies on ONGC, Dr Reddy's, Cipla and Coal India.
- Dr Reddy's Lab can Touch 1,950: HSBCHSBC has reiterated its 'Overweight' rating on Dr Reddy's Lab and set a target price of 1,950.
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- New meningitis vaccine for infants shows promiseA new vaccine, Menveo, has shown promise in clinical trials, which might help protect infants against four types of meningitis.
- Glenmark gets DGCI nod for drug trialGlenmark Pharmaceuticals Ltd today said it has received approval from the Drug Controller General of India (DCGI) to initiate phase II tria...
Load More
